Colgate-Palmolive India Q3 Results: Profit Declines Marginally, Meets Market Expectations
Colgate-Palmolive (India) Ltd., the maker of the popular Colgate toothpaste, has announced its financial results for the third quarter of fiscal year 2025 (Q3 FY25). The company reported a slight decline in net profit, which nonetheless aligned with analysts' projections.
Financial Performance Overview
For the quarter ended December 2024, Colgate-Palmolive India reported a net profit of Rs 323 crore, representing a 2.2% decrease from Rs 330 crore in the same period last year. While the profit dipped slightly, it met the consensus estimate
Key Financial Highlights (Consolidated, YoY)
- Revenue: Increased by 4.7% to Rs 1,462 crore from Rs 1,396 crore.
- EBITDA: Decreased by 3% to Rs 454 crore from Rs 468 crore. (Estimate: Rs 470 crore)
- Margin: Contracted by 250 basis points to 31.1% from 33.6%. (Estimate: 31.50%)
- Net Profit: Declined by 2.2% to Rs 323 crore from Rs 330 crore. (Estimate: Rs 335 crore)
Despite a slight dip in profit and a contraction in EBITDA margin, Colgate-Palmolive India's revenue saw a moderate increase of 4.7% during the quarter. The results reflect the company's performance within the competitive landscape of the fast-moving consumer goods (FMCG) sector.
Colgate-Palmolive India's Q3 FY25 results indicate a stable performance, with the company managing to meet market expectations despite a slight decrease in profitability. The results are indicative of the ongoing dynamics within the FMCG industry and the broader economic environment.
Disclaimer: The views and investment tips expressed in this article are for informational purposes only and do not represent financial advice. The views expressed are those of the sources cited and not necessarily those of this website or its management. Investing in equities or other financial instruments carries the risk of financial loss. Readers must exercise due caution and conduct their own research before making any investment decisions. We are not liable for any losses incurred as a result of decisions made based on this article. Please consult a qualified financial advisor before making any investment.
0 comments:
Post a Comment